We haven't done any research on the cost-effectiveness component of that in terms of cancer. We've looked at cardiovascular disease and we've looked at the cost effectiveness of including a naturopathic approach to care for people who are at higher risk for cardiovascular disease. This was actually a study in three centres across Canada involving Canada Post workers. We showed dramatic societal benefits in terms of cost effectiveness there. I think it was just over a thousand dollars per individual.
That's representative of a kind of chronic disease that responds to a whole-person approach to care. Cancer is definitely a chronic disease now. It's more of a disease that is managed rather than attempted to be cured, so it fits very well within that.
We do need to do the cost-effectiveness research to see what benefits there are there, especially if we're able to prevent recurrence. There is no question there would be a massive benefit from that.
In a lot of the cases, people will come to us after conventional therapy. They've just finished their chemotherapy, their radiation, and they wonder what they do now. They feel let go and they don't know what else to do.
Complementary practitioners are often a place that people will go for that. That's definitely an area where we see patients. My bias is very strong that we're able to improve recurrence rates, and there is data for that as well.